ArticleNeuro-oncology2018
Lower-grade gliomas: the wrong target for bevacizumab.
David Schiff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleNeuro-oncology2018
David Schiff et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.